In many ways they mirror the diverse focuses of the Chemical Manufacturers Association itself.

Both are closely woven into the fabric of the Association's activities.

Share of cosmetic products and product versions containing PFAS*. ............. 53 Table A.31.

Roland President Chem'u-al Manufacturers Association SL 068062 ADVOCACY uring the year, 46 CHEMSTAK Panels anti Councils focused their efforts on regulatory advocacy.

The Association's implementation of Total Quality From that first phosgene project in which Management will even further refine the pro member companies pooled $30,000 to support cesses by which panels and councils, and the research on safety improvement.

McCORMICK, Editor Associate Editors, GORDON II.

Til: Jeppe Kramer Jrgensen (EM-DEP) ( @em.dk) Fra: Stellan Nrreskov Wulff (ffi@medicoindustrien.dk) Titel: SV: Mde ml.

. (\' i MedTech Europe from diagnosis to cure A Mrs Stella Kyriakides Commissioner for Health and Food Safety European Commission Rue de la Loi 200 B-1049 Brussels Brussels, 04-Dec-2023 Potential nomination of siloxanes D4, D5, and D6 to the Stockholm Convention on Persistent Organic Pollutants (POPs): securing patients' access to medical technologies Dear Commissioner, dear Mrs Kyriakides, On behalf of MedTech Europe, the European trade association representing the medical technology industry, I am contacting you today to raise your attention to the significant implications that a potential nomination of the siloxanes D4, D5 and D6 to the Stockholm Convention would entail for the medical technology sector, healthcare practitioners and patients who depend on continuous, uninterrupted supply of life-saving and life-sustaining medical technologies to satisfy their daily healthcare needs. (1) MedTech Europe is concerned with the significant risk posed by such a nomination on the vital use of D4, D5 and D6 in the manufacturing of silicone polymers, which are essential for the manufacture and use of many medical technology applications, including both medical devices and IVDs.1 (2) Additionally, the three siloxanes have been the subject of multiple regulatory measures in the European Union (EU) since 2017 by virtue of a REACH2 Restriction proposal3.

. (\' i MedTech Europe from diagnosis to cure A Mrs Stella Kyriakides Commissioner for Health and Food Safety European Commission Rue de la Loi 200 B-1049 Brussels Brussels, 04-Dec-2023 Potential nomination of siloxanes D4, D5, and D6 to the Stockholm Convention on Persistent Organic Pollutants (POPs): securing patients' access to medical technologies Dear Commissioner, dear Mrs Kyriakides, On behalf of MedTech Europe, the European trade association representing the medical technology industry, I am contacting you today to raise your attention to the significant implications that a potential nomination of the siloxanes D4, D5 and D6 to the Stockholm Convention would entail for the medical technology sector, healthcare practitioners and patients who depend on continuous, uninterrupted supply of life-saving and life-sustaining medical technologies to satisfy their daily healthcare needs. (1) MedTech Europe is concerned with the significant risk posed by such a nomination on the vital use of D4, D5 and D6 in the manufacturing of silicone polymers, which are essential for the manufacture and use of many medical technology applications, including both medical devices and IVDs.1 (2) Additionally, the three siloxanes have been the subject of multiple regulatory measures in the European Union (EU) since 2017 by virtue of a REACH2 Restriction proposal3.

The company retained the oil and gas reserves formerly associated with Lion and continues active do mestic production and exploration programs.

The company retained the oil and gas reserves formerly associated with Lion and continues active do mestic production and exploration programs.

A second factor having a negative effect on earnings for 1972 was the write-off of the goodwill associated with the company's investment in Lansil Ltd., resulting in a $4.2 million reduction of net income.

The conditions proposed under RO2 are as follows: transitional period of 18 months for entry into force; a series of derogations limited in time (from 5 to 12 years); the only unlimited derogations concern active substances in biocidal products, plant protection products and human and veterinary medicinal products; anything that does not fall within the two previous cases and not expressly specified in the proposed derogations, will be banned at the end of the transitional period (e.g. food contact material for consumer use, non-stick pans, cosmetics, household products, etc.); As indicated by the authorities that prepared the restriction dossier, RO2 is considered the most proportionate and balanced scenario (p. 3 PFAS Restriction Report).

The conditions proposed under RO2 are as follows: transitional period of 18 months for entry into force; a series of derogations limited in time (from 5 to 12 years); the only unlimited derogations concern active substances in biocidal products, plant protection products and human and veterinary medicinal products; anything that does not fall within the two previous cases and not expressly specified in the proposed derogations, will be banned at the end of the transitional period (e.g. food contact material for consumer use, non-stick pans, cosmetics, household products, etc.); As indicated by the authorities that prepared the restriction dossier, RO2 is considered the most proportionate and balanced scenario (p. 3 PFAS Restriction Report).

Adhesives Manufacturers Association Aerospace Industries Alliance of American Insurers American Chemical Society American Conference of Chemical Labeling American Industrial Hygiene Association American Institute of Chemical Engineers American Insurance Association American Iron and Steel Institute American Occupational Medical Association American Petroleum Institute American Society of Safety Engineers Associated General Contractors of America Can Manufacturers Institute Chemical Specialities Manufacturers Association Compressed Gas Association Consumer Product Safety Commission Cosmetics Toiletry Fragrance Association Factory Mutual Association Foundry Supply Manufacturing Group General Services Administration -- Federal Property Resources Services Industrial Risk Insurers International Chemical Workers Union Kalamazoo Label Company Motor Vehicle Manufacturers Association National Agricultural Chemicals Association National Bureau of Standards National Fire Protection Association National Institute of Occupational Safety and Health National Paint and Coatings Association National Safety Council Naval Research Laboratory Naval Supply Systems Command Rubber Manufacturers Association Soap and Detergent Association Society of the Plastics Industry Society of Toxicology Synthetic and Organic Chemicals Manufacturers Association Underwriters Laboratories U.S.